期刊文献+

乳腺癌标记物研究现状和进展 被引量:1

Current situation and progress of breast cancer markers
原文传递
导出
摘要 乳腺癌是女性的高发恶性肿瘤,多年的研究表明乳腺癌属全身性疾病,即使早期乳腺癌,也会发生隐匿性转移。通过对乳腺癌相关肿瘤抗原及标记物的综合研究分析,可以对其发生、恶性程度、预后等作出及时的判断,指导治疗,合理控制肿瘤,提高患者生存期和生活质量。 Breast cancer is a malignant cancer of high incidence among females. Long-term studies indicate that breast cancer is the systematic disease of the whole body. Breast cancer may transfer cryptically even if in its initial stage. Through comprehensive research and analysis of tumor antigen and marker, we can make the judgement of its genesis, malignancy grade and prognosis in time to guide the the therapy, control the cancer, prolong patients survival and enhance their life quality.
出处 《国际肿瘤学杂志》 CAS 2007年第9期673-676,共4页 Journal of International Oncology
关键词 乳腺肿瘤 肿瘤标记 生物学 Breast neoplasms Tumor markers, biological
  • 相关文献

参考文献1

二级参考文献4

共引文献62

同被引文献6

  • 1江泽飞,徐兵河,宋三泰,孙燕.乳腺癌内分泌治疗的基本共识[J].中华肿瘤杂志,2006,28(3):238-239. 被引量:48
  • 2Cooke T,Reeves J,Lannigan A,et al.The value of the human epidermal growth factor receptor-2(HER 2) as prognostic marker[J].EurCancer,2001,37:3-10.
  • 3Horiguchi J,Koibuchi Y,Lijima K,et al.Co-expressed type of ER and HER-2 predictive in determining resistance to antiestrogen therapy in patients with ER-positive and HER-2-positive breast cancer[J].Oncol Pep,2005,14:1109-1116.
  • 4Petit T,Wilt M,Velten M,et al.Comparative value of tumor grade,hormaonal receptors,Ki67,HER-2 and topoisomerase 11 alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy[J].Eur J,Cancer,2004,40:205-211.
  • 5Faneyte IF,Schrama JG,Peterse JL,et al.Breast cancer response to neoadjuvant chemtherapy:predicite markers and relation with outcome[J].Br J Cancer,2003,88:406-412.
  • 6陈世荣,樊峰,赵一平.HER-2和ER、PR在乳腺癌中的表达及其意义[J].苏州大学学报(医学版),2007,27(5):745-747. 被引量:6

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部